Latest Articles
VIDEO: Molecular profiling may soon guide endometrial cancer treatment decisions - Healio
VIDEO: Molecular profiling may soon guide endometrial cancer treatment decisions Healio
Published: April 14, 2025, 6:21 p.m.
Real-World Use of ICI in Advanced or Recurrent Endometrial Cancer - OncLive
Real-World Use of ICI in Advanced or Recurrent Endometrial Cancer OncLive
Published: April 14, 2025, 2:41 p.m.
Rethinking Immunotherapy: A Case for Personalization in Advanced Endometrial Cancer - HMP Global Learning Network
Rethinking Immunotherapy: A Case for Personalization in Advanced Endometrial Cancer HMP Global Learning Network
Published: April 11, 2025, 2:54 p.m.
Predicting Recurrence Risk in Endometrial Cancer: A Multisequence MRI Intratumoral and Peritumoral Radiomics Nomogram Approach - Frontiers
Predicting Recurrence Risk in Endometrial Cancer: A Multisequence MRI Intratumoral and Peritumoral Radiomics Nomogram Approach Frontiers
Published: April 10, 2025, 3:24 p.m.
S2 Episode 4: Immunotherapy Insights and Research in Endometrial Cancer - Medscape
S2 Episode 4: Immunotherapy Insights and Research in Endometrial Cancer Medscape
Published: April 10, 2025, 2:07 p.m.
Disparities in End-of-Life Outcomes: A Demographic and Geographic Analysis of Endometrial Cancer Deaths in the United States - Cureus
Disparities in End-of-Life Outcomes: A Demographic and Geographic Analysis of Endometrial Cancer Deaths in the United States Cureus
Published: April 10, 2025, 7:35 a.m.
Oroxylin A may promote cell apoptosis and inhibit epithelial-mesenchymal transition in endometrial cancer, associated with the ERβ/PI3K/AKT pathway - Nature
Oroxylin A may promote cell apoptosis and inhibit epithelial-mesenchymal transition in endometrial cancer, associated with the ERβ/PI3K/AKT pathway Nature
Published: April 10, 2025, 6:55 a.m.
ASCO Reading Room | Daniela Matei on Chemotherapy for Stage III Endometrial Cancer - MedPage Today
ASCO Reading Room | Daniela Matei on Chemotherapy for Stage III Endometrial Cancer MedPage Today
Published: April 9, 2025, 3:15 p.m.
Dr Konstantinopoulos on Responses With Metformin Plus Letrozole/Abemaciclib in ER+ Endometriod Endometrial Cancer - OncLive
Dr Konstantinopoulos on Responses With Metformin Plus Letrozole/Abemaciclib in ER+ Endometriod Endometrial Cancer OncLive
Published: April 9, 2025, 2 p.m.
After comparing endometrial cancer minimally invasive surgery, laparotomy, survival rate and complications... - MSN
After comparing endometrial cancer minimally invasive surgery, laparotomy, survival rate and complications... MSN
Published: April 9, 2025, 12:35 a.m.
Link copied to clipboard!